Phaos Technology Holdings (Cayman) (POAS) Work In Process (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Work In Process of $39665.2 for Q2 2025, up 122.8% on a QoQ basis from $17803.2 in Q2 2024, and up 122.8% year-over-year from $17803.2 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) Work In Process (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Work In Process history runs 2 years deep, the most recent figure standing at $39665.2 for Q2 2025.
- Quarterly Work In Process rose 122.8% year-over-year to $39665.2 in Q2 2025, while the trailing twelve-month figure through Apr 2025 was $39665.2 (up 122.8% YoY) and the FY2025 annual result came in at $40614.0, up 128.13% from the prior year.
- Work In Process was $39665.2 for Q2 2025 at Phaos Technology Holdings (Cayman), up from $17803.2 in the prior quarter.
- Across five years, Work In Process topped out at $39665.2 in Q2 2025 and bottomed at $17803.2 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.17 Mn | 6.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 39,665.18 |
| Apr 30, 2024 | 17,803.24 |